In future studies, we will evaluate the crosstalk between DCs and TAMs in mouse models of pancreatic cancer and the extent to which targeting DCs resembles the efficacy of anti–CSF-1R treatment in vivo. This evidence concerns the gene CSF1R and pancreatic neoplasm.